Search from website


20 March 2023

Icosagen Acquires the Carterra LSA Instrument to Significantly Enhance Its Antibody Screening Capabilities in the Discovery and Development of New Therapeutic and Diagnostic Antibodies

08 February 2023

PRESS RELEASE: InvestEU: EIB agrees to €18 million loan to Estonian biotech Icosagen for innovative R&D technologies and new cGMP production facility

22 December 2022

Holiday greetings

12 December 2022

PRESS RELEASE: Icosagen Chooses Genedata Biologics to Digitalize Recombinant Antibody Discovery

Shopping Cart